Jasper Ridge Partners’s Agios Pharmaceuticals AGIO Stock Holding History

Jasper Ridge Partners’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-32,998	Closed	-$3.11M	–	91
2015 Q1	$3.11M	Buy	+32,998	New	+$3.7M	0.23%	32
2014 Q3	–	Sell	-22,096	Closed	-$1.01M	–	114
2014 Q2	$1.01M	Buy	+22,096	New	+$901K	0.07%	67

Other funds holding AGIO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

FV2GP

Flagship Ventures 2007 General Partner Cambridge, Massachusetts $107M AUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

CGT

Capital Guardian Trust Los Angeles, California $7.42B AUM 13.6% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Jasper Ridge Partners's AGIO Position: Q2 2015 in Review

Jasper Ridge Partners sold out of Agios Pharmaceuticals (AGIO) in Q2 2015, closing a stake of 32,998 shares — an estimated $3.11M sold.

Jasper Ridge Partners first reported a position in AGIO in Q2 2014 and held it in 2 quarters. The position peaked at $3.11M in Q1 2015. 162 funds tracked by Wall St. Rank hold AGIO as of Q2 2015.

Jasper Ridge Partners reported no remaining Agios Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
Jasper Ridge Partners sold 32,998 Agios Pharmaceuticals shares in Q2 2015, an estimated $3.11M.
Jasper Ridge Partners first reported a position in Agios Pharmaceuticals in Q2 2014 and held it in 2 quarters.
Jasper Ridge Partners's Agios Pharmaceuticals position peaked at $3.11M in Q1 2015.
162 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2015.

Based on Jasper Ridge Partners's 13F filing for Q2 2015, filed 13 Aug 2015.